Suven Pharmaceuticals Ltd
NSE:SUVENPHAR
Wall Street
Price Targets
SUVENPHAR Price Targets Summary
Suven Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for SUVENPHAR is 816 INR with a low forecast of 808 INR and a high forecast of 840 INR.
Operating Income
Forecast
Operating Income Estimate
Suven Pharmaceuticals Ltd
For the last 3 years the compound annual growth rate for Suven Pharmaceuticals Ltd's operating income is 13%. The projected CAGR for the next 3 years is 8%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SUVENPHAR's stock price target?
Price Target
816
INR
According to Wall Street analysts, the average 1-year price target for SUVENPHAR is 816 INR with a low forecast of 808 INR and a high forecast of 840 INR.
What is Suven Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
5%
For the last 3 years the compound annual growth rate for Suven Pharmaceuticals Ltd's revenue is 17%. The projected CAGR for the next 3 years is 5%.
What is Suven Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
8%
For the last 3 years the compound annual growth rate for Suven Pharmaceuticals Ltd's operating income is 13%. The projected CAGR for the next 3 years is 8%.
What is Suven Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
8%
For the last 3 years the compound annual growth rate for Suven Pharmaceuticals Ltd's net income is 9%. The projected CAGR for the next 3 years is 8%.